Retour
Fourchette du Jour
97,00 €
101,45 €
Fourchette 52 Semaines
55,00 €
169,90 €
Volume
200
Moyenne 50J / 200J
140,81 €
/
98,97 €
Clôture Précédente
95,19 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -452,4 | 0,4 |
| P/B | 3,4 | 2,9 |
| ROE % | -0,7 | 3,7 |
| Net Margin % | -3,5 | 3,8 |
| Rev Growth 5Y % | 12,7 | 10,0 |
| D/E | 0,0 | 0,2 |
Points Clés
Revenue grew 12,66% annually over 5 years — strong growth
Earnings declined -102,72% over the past year
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -15,84M
Revenue growth is decelerating — 1Y growth trails 5Y average by 73,37%
Capital efficient — spends only 4,04% of revenue on capex
Croissance
Revenue Growth (5Y)
12,66%
Revenue (1Y)-60,71%
Earnings (1Y)-102,72%
FCF Growth (3Y)N/A
Qualité
Return on Equity
-0,74%
ROIC-1,62%
Net Margin-3,46%
Op. Margin-10,00%
Sécurité
Debt / Equity
0,01
Current Ratio7,18
Interest Coverage-57,54
Valorisation
P/E Ratio
-452,43
P/B Ratio3,41
EV/EBITDAN/A
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -60,71% | Revenue Growth (3Y) | 6,29% |
| Earnings Growth (1Y) | -102,72% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12,66% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 104,82M | Net Income (TTM) | -3,63M |
| ROE | -0,74% | ROA | -0,59% |
| Gross Margin | 46,53% | Operating Margin | -10,00% |
| Net Margin | -3,46% | Free Cash Flow (TTM) | -15,84M |
| ROIC | -1,62% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 7,18 |
| Interest Coverage | -57,54 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | -452,43 | P/B Ratio | 3,41 |
| P/S Ratio | 15,67 | PEG Ratio | 4,84 |
| EV/EBITDA | N/A | Dividend Yield | 0,02% |
| Market Cap | 1,64B | Enterprise Value | 1,59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 104,82M | 266,79M | 92,78M | 102,09M | 65,07M |
| Net Income | -3,63M | 133,24M | -4,93M | 17,23M | 21,67M |
| EPS (Diluted) | -0,23 | 8,12 | -0,31 | 1,05 | 1,28 |
| Gross Profit | 48,77M | 246,92M | 53,44M | 83,33M | 49,93M |
| Operating Income | -10,48M | 148,88M | 6,15M | 28,06M | 11,10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 611,97M | 646,77M | 553,98M | 759,59M | 805,56M |
| Total Liabilities | 123,32M | 141,68M | 124,94M | 295,80M | 292,88M |
| Shareholders' Equity | 481,78M | 498,33M | 422,16M | 456,93M | 505,28M |
| Total Debt | 4,26M | 2,20M | 1,84M | 173,60M | 169,92M |
| Cash & Equivalents | 55,80M | 44,30M | 50,28M | 185,83M | 198,56M |
| Current Assets | 183,08M | 202,26M | 102,23M | 306,10M | 275,85M |
| Current Liabilities | 25,49M | 48,27M | 25,71M | 194,95M | 21,24M |